These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19140229)

  • 21. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
    Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [MicroRNA profiling in patients with hepatocellular carcinoma].
    Wang CX; Song W; Li ZJ; Song B; Wu DH; Sun AM; Chen LH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):976-7. PubMed ID: 20501372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.
    Iyer JK; Kalra M; Kaul A; Payton ME; Kaul R
    World J Gastroenterol; 2017 Oct; 23(37):6802-6816. PubMed ID: 29085224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression.
    Wang Y; Li J; Chen J; Liu L; Peng Z; Ding J; Ding K
    Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):995-1000. PubMed ID: 22913147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules.
    Quagliata L; Andreozzi M; Kovac M; Tornillo L; Makowska Z; Moretti F; Heim MH; Heinimann K; Piscuoglio S; Terracciano LM
    Eur J Cancer; 2014 Mar; 50(4):731-8. PubMed ID: 24315626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
    Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
    J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis.
    Miyakawa H; Izumi N; Marumo F; Sato C
    Alcohol Clin Exp Res; 1996 Feb; 20(1 Suppl):91A-94A. PubMed ID: 8659700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
    Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
    Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
    Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
    Terada T; Terasaki S; Nakanuma Y
    Cancer; 1993 Sep; 72(5):1551-6. PubMed ID: 8394196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.
    Tan Y; Lin B; Ye Y; Wen D; Chen L; Zhou X
    Oncol Rep; 2015 Jun; 33(6):2863-70. PubMed ID: 25962820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling.
    Pu XY; Zheng DF; Shen A; Gu HT; Wei XF; Mou T; Zhang JB; Liu R
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):408-415. PubMed ID: 30201411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
    Huang XX; McCaughan GW; Shackel NA; Gorrell MD
    Liver Int; 2007 Sep; 27(7):960-8. PubMed ID: 17696935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.
    Coulouarn C; Derambure C; Lefebvre G; Daveau R; Hiron M; Scotte M; François A; Daveau M; Salier JP
    J Hepatol; 2005 Jun; 42(6):860-9. PubMed ID: 15885357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients.
    Sakai Y; Honda M; Fujinaga H; Tatsumi I; Mizukoshi E; Nakamoto Y; Kaneko S
    Cancer Res; 2008 Dec; 68(24):10267-79. PubMed ID: 19074895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of tumour suppressor genes
    El-Bendary M; Nour D; Arafa M; Neamatallah M
    Br J Biomed Sci; 2020 Jan; 77(1):35-40. PubMed ID: 31790342
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
    Zheng Y; Hlady RA; Joyce BT; Robertson KD; He C; Nannini DR; Kibbe WA; Achenbach CJ; Murphy RL; Roberts LR; Hou L
    Clin Epigenetics; 2019 Oct; 11(1):145. PubMed ID: 31639042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.